Circulating levels of sclerostin are associated with cardiovascular mortality-Reference-Cited by-同舟云学术

Circulating levels of sclerostin are associated with cardiovascular mortality

Published:2018-06-21 Issue:6 Volume:13 Page:e0199504
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Novo-Rodríguez Cristina^ORCID,García-Fontana Beatriz^ORCID,Luna-Del Castillo Juan De Dios,Andújar-Vera Francisco^ORCID,Ávila-Rubio Verónica^ORCID,García-Fontana Cristina^ORCID,Morales-Santana Sonia,Rozas-Moreno Pedro^ORCID,Muñoz-Torres Manuel^ORCID

Funder

Instituto de Salud Carlos III

Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía

FEDER

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts);J Perk;Eur Heart J,2012

2. Cellular and molecular mechanisms of vascular injury in diabetes—part I: pathways of vascular disease in diabetes;R Madonna;Vascul Pharmacol,2011

3. Prediction of coronary heart disease using risk factor categories;PW Wilson;Circulation,1998